Jane Street’s Cue Biopharma CUE Stock Holding History

Jane Street’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$933K	Buy	+36,071	New	+$1.07M	﹤0.01%	6616
2026 Q1	–	Sell	-2,326	Closed	-$21.3K	–	11787
2025 Q4	$21.3K	Buy	+2,326	New	+$42.7K	﹤0.01%	10713
2025 Q1	–	Sell	-2,126	Closed	-$69.5K	–	9595
2024 Q4	$69.5K	Buy	2,126 +1,261	+146%	+$47.4K	﹤0.01%	8880
2024 Q3	$19.6K	Sell	865 -2,422	-74%	-$52.5K	﹤0.01%	9297
2024 Q2	$122K	Buy	+3,287	New	+$163K	﹤0.01%	8653
2024 Q1	–	Sell	-1,821	Closed	-$144K	–	9321
2023 Q4	$144K	Buy	+1,821	New	+$130K	﹤0.01%	8414
2023 Q2	–	Sell	-899	Closed	-$96.3K	–	8801
2023 Q1	$96.3K	Buy	+899	New	+$85.7K	﹤0.01%	8246
2020 Q3	–	Sell	-419	Closed	-$308K	–	7230
2020 Q2	$308K	Buy	+419	New	+$304K	﹤0.01%	5795

Other funds holding CUE

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Advisory Research Chicago, Illinois $943M AUM 29.52% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Jane Street's CUE Position: Q3 2026 in Review

Jane Street opened a new position in Cue Biopharma (CUE) in Q3 2026: 36,071 shares worth $933K. The stake represents ﹤0.01% of the portfolio and ranks #6616 among its holdings. This is a return to the name: Jane Street previously reported a position in CUE as recently as Q4 2025.

Jane Street first reported a position in CUE in Q2 2020 and has held it in 8 quarters since. 26 funds tracked by Wall St. Rank hold CUE as of Q3 2026.

Jane Street held 36,071 shares of Cue Biopharma worth $933K as of Q3 2026.
Cue Biopharma was a new Jane Street position in Q3 2026.
Cue Biopharma made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #6616 holding.
Jane Street first reported a position in Cue Biopharma in Q2 2020 and has held it in 8 quarters since.
26 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.